Zuzana Jendželovská Selected Research

Proadifen

1/2016	Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin.
10/2015	Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zuzana Jendželovská Research Topics

Disease

6	Neoplasms (Cancer) 05/2022 - 10/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2014
2	Leukemia 01/2019 - 10/2015
1	Colorectal Neoplasms (Colorectal Cancer) 06/2019
1	Carcinoma (Carcinomatosis) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Adenocarcinoma 01/2016
1	Necrosis 01/2016

Drug/Important Bio-Agent (IBA)

4	hypericinIBA 06/2019 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 06/2019 - 10/2014
4	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 10/2014
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2022 - 06/2019
2	multidrug resistance-associated protein 1IBA 01/2019 - 10/2014
2	ProadifenIBA 01/2016 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 10/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2015 - 10/2014
1	hyperforinIBA 06/2019
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2015
1	Apoptosis Regulatory ProteinsIBA 10/2015

Therapy/Procedure

3	Photochemotherapy (Photodynamic Therapy) 05/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 05/2022 - 10/2015